Literature DB >> 18266692

Ultrastructural findings in progressive macular hypomelanosis indicate decreased melanin production.

G N Relyveld1, K P Dingemans, H E Menke, J D Bos, W Westerhof.   

Abstract

BACKGROUND: The pathogenesis of progressive macular hypomelanosis (PMH) is unknown. Recently, Westerhof et al. (Arch Dermatol 2004; 140: 210-214) hypothesized that Propionibacterium acnes produces a depigmenting factor that interferes with melanogenesis in the skin, resulting in hypopigmented spots. The purpose of the study is to gain an insight into the pathogenesis of PMH.
MATERIALS AND METHODS: We took a biopsy of 2-mm diameter from normal and lesional skin in eight PMH patients. Using electron microscopy, we compared melanization of melanosomes, melanosome transfer and amount of epidermal melanin in normal and lesional skin. RESULT: Compared to non-lesional skin, we observed a decrease of epidermal melanin and less melanized melanosomes in lesional skin of all patients. When comparing normal and lesional skin of patients with skin type V and VI, we observed a difference in melanosome size and maturation and a switch of transferred melanosomes from single stage IV transferred melanosomes to aggregated stage I, II and III transferred melanosomes, as seen in healthy skin of skin type I to IV.
CONCLUSION: Hypopigmentation in PMH seems to be the result of an altered melanogenesis based on a decrease in melanin formation and a change in the distribution of melanosomes. In lesional skin of PMH patients with skin type V and VI less melanized, aggregated melanosomes in stead of single, mature melanosomes are transferred from melanocytes to keratinocytes. This results in a decrease of epidermal melanin. Further investigations are needed to determine the precise role of Propionibacterium acnes in this alteration of melanogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266692     DOI: 10.1111/j.1468-3083.2007.02515.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  4 in total

1.  Progressive macular hypomelanosis in korean patients: a clinicopathologic study.

Authors:  Seon Wook Hwang; Soon Kwon Hong; Sang Hyun Kim; Jeong Hoon Park; Jong Keun Seo; Ho Suk Sung; Deborah Lee
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

2.  Progressive macular hypomelanosis: a rarely diagnosed hypopigmentation in Caucasians.

Authors:  Sven Neynaber; Christina Kirschner; Stefanie Kamann; Gerd Plewig; Michael J Flaig
Journal:  Dermatol Res Pract       Date:  2009-06-01

3.  Progressive macular hypomelanosis among Egyptian patients: a clinicopathological study.

Authors:  Mohamed Khaled Selim; El-Shahat Farag Ahmed; Mamdouh Morsy Abdelgawad; Mohammed Fawzy El-Kamel
Journal:  Dermatol Pract Concept       Date:  2011-01-31

4.  Propionibacterium Acnes Phylogenetic Type III is Associated with Progressive Macular Hypomelanosis.

Authors:  Rolf L W Petersen; Christian F P Scholz; Anders Jensen; Holger Brüggemann; Hans B Lomholt
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.